Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies
Complete removal of the EV ICD lead was successful in 93.1% of cases, and simple traction was sufficient in most instances. Based on these results, lead removal from the substernal space was safe and achievable up to 3 years post-implant.
Authors
- R. Denman (ORCID: https://orcid.org/0000-0003-4819-6922)
- Bradley P. Knight (ORCID: https://orcid.org/0000-0002-2129-0401)
- Paul A. Friedman (ORCID: https://orcid.org/0000-0001-5052-2948)
- Venkata Sagi
- Christopher Wiggenhorn
- Thomas Holmes (ORCID: https://orcid.org/0000-0002-4651-0079)
- Christophe Leclercq (ORCID: https://orcid.org/0000-0002-4399-5568)
- Ian Crozier (ORCID: https://orcid.org/0000-0003-4652-7791)
- Ulrika Birgersdotter‐Green (ORCID: https://orcid.org/0000-0002-0473-1826)
- Haris M. Haqqani (ORCID: https://orcid.org/0000-0003-1543-6686)
- Henri Roukoz (ORCID: https://orcid.org/0000-0002-8011-0829)
- Thomas Lulic
- Jaimie Manlucu (ORCID: https://orcid.org/0000-0001-9968-6388)
- Francis Murgatroyd (ORCID: https://orcid.org/0000-0002-5527-7504)
- Anish K. Amin (ORCID: https://orcid.org/0000-0002-9768-7595)
- Mauro Biffi (ORCID: https://orcid.org/0000-0003-4590-8584)
- Lucas V.A. Boersma (ORCID: https://orcid.org/0000-0003-4591-4220)
- Joseph Yat Sun Chan (ORCID: https://orcid.org/0000-0002-3356-4836)
Institutions
- Northwestern University (US)
- University of Minnesota (US)
- Mayo Clinic (US)
- Chinese University of Hong Kong (HK)
- Riverside Methodist Hospital (US)
- London Health Sciences Centre (CA)
- WinnMed (US)
- Christchurch Hospital (NZ)
- University Medical Center (US)
- Medtronic (Ireland) (IE)
- University of California San Diego (US)
- Medtronic (United States) (US)
- Holy Spirit Northside Private Hospital (AU)
- St Vincent’s Private Hospital Sydney (AU)
- Northwestern University (PH)
- St. Antonius Ziekenhuis (NL)
- Amsterdam Neuroscience (NL)
- Prince of Wales Hospital (CN)
- Azienda USL di Bologna (IT)
- Hôpital Pontchaillou (FR)
- Mayo Clinic in Arizona (US)
- University of California San Diego Medical Center (US)
- Northwestern Medicine (US)
- Amsterdam University Medical Centers (NL)
- King's College Hospital (GB)
- Centre Hospitalier Universitaire de Rennes (FR)
- Dermatology Specialists (US)
- University of Amsterdam (NL)
Publication Details
- Journal
- EP Europace
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1093/europace/euae225
- Citations
- 19
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 7.64
Funders
- Medtronic
- AtriCure
- Boston Scientific Corporation
- Biosense Webster